In June 2022, „Good Morning America“ ran a segment about a drug being described as a cancer treatment breakthrough. ABC News’ medical correspondent, Jennifer Ashton, joined host Lara Spencer to explain that a new study published in The New England Journal of Medicine revealed that Enhertu, a cancer drug co-developed by AstraZeneca and Daiichi Sankyo, could help patients suffering from some types of breast cancer to live longer. While Ashton makes it clear that the drug is not a cure, she stresses that it does give patients more time.
Survival Story: Enhertu
Kommentar
Teilen
